Bacha Jeffrey Insider Trades

Insider Trading History

Track insider trading activity for Bacha Jeffrey. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $13.8k 64,049 shares
Last Trade
Mar 30, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.9M 176 shares
$16,449.99
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $13.8k 63,873 shares
Last Trade
Dec 31, 2017 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$3.36M 176 shares
$19,074.99
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $20.2k 93,600 shares
Last Trade
Dec 22, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.14B 218,600 shares
$14,351.74
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $0 0 shares
Last Trade
Dec 22, 2017 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.14B 218,600 shares
$14,351.74
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $13.7k 63,697 shares
Last Trade
Oct 06, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$155M 10,000 shares
$15,469.99
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $11.6k 53,697 shares
Last Trade
Sep 29, 2017 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.59M 176 shares
$14,699.99
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $11.5k 53,521 shares
Last Trade
Jun 30, 2017 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$7.05M 176 shares
$40,074.97
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $11.5k 53,345 shares
Last Trade
Jun 26, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$256M 6,700 shares
$38,149.97
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $10k 46,645 shares
Last Trade
Jun 06, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$178M 5,000 shares
$35,699.97
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Executive Officer
Holding Value $8.97k 41,645 shares
Last Trade
May 05, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$98.4M 2,500 shares
$39,374.97
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Executive Officer
Holding Value $8.43k 39,145 shares
Last Trade
Mar 31, 2017 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$12.9M 176 shares
$73,499.95
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $20.2k 93,600 shares
Last Trade
Feb 17, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.11B 93,600 shares
$86,624.94
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $8.39k 38,969 shares
Last Trade
Feb 01, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$361M 4,000 shares
$90,152.93
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $7.53k 34,969 shares
Last Trade
Dec 31, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$9.82M 176 shares
$55,807.46
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $7.49k 34,793 shares
Last Trade
Oct 03, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$18.6M 176 shares
$105,874.92
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
CEO
Holding Value $7.46k 34,617 shares
Last Trade
Jul 18, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$18.5M 120 shares
$153,999.89
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Ceo, Director
Holding Value $673 3,125 shares
Last Trade
Apr 29, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$260M 3,125 shares
$83,300.09
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
10% owner, Ceo, Director
Holding Value $29.7k 137,985 shares
Last Trade
Nov 25, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$793M 7,500 shares
$105,700.11
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
10% owner, President, CEO
Holding Value $28.1k 130,485 shares
Last Trade
Oct 08, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$182M 3,000 shares
$60,830.06
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
10% owner, President, CEO
Holding Value $27.5k 127,485 shares
Last Trade
Sep 18, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$231M 4,000 shares
$57,750.06
$0.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up